-
13 June 2022
Opportunity for Evaluation of Diagnostic Products – Syphilis Diagnosis
-
20 May 2022
External Quality Assessment: Highest Possible Results for OIG Audit and Investigation Units
-
20 May 2022
New Isoniazid/rifapentine and rifapentine generic for tuberculosis (TB) prevention recently recommended for use by ERP
-
10 May 2022Pandemic Preparedness and Response - Thematic Report
-
03 May 2022
Global Fund Appoints Susie Rhee as General Counsel and Head of the Legal & Governance Department
-
29 April 2022Conflicts, Crises and Displaced People: How the Global Fund Works in Challenging Operating Environments - Thematic Report
-
08 April 2022
Opportunity for Evaluation of Diagnostic Products
-
08 April 2022
Message from the Executive Director: Global Fund Grants in Liberia
-
08 April 2022
Liberia: Fraudulent and Abusive Practices in Global Fund Programs
-
06 April 2022
Message from the Executive Director: Global Fund Grants in Nigeria
-
05 April 2022
Virtual Press Briefing: A Strategy to Manage Long-Term Risks of COVID-19
-
30 March 2022
Audit of the COVID-19 Response Mechanism 2021